Werner Kroll

Biography

 Werner Kroll became SVP, Research & Development for Quidel in May 2014. Dr. Kroll is responsible for all aspects of research and development of the Company’s immunoassay and molecular products, from initial concept through to manufacturability. Prior to joining Quidel, Dr. Kroll was Vice President and Global Head of Research and Innovation for Novartis Molecular Diagnostics/Codiagnostics. He has also held senior positions at Novartis Pharmaceuticals, Bayer Diagnostics and Bayer Pharmaceuticals, and AGFA. In addition, Dr. Kroll serves on the board of directors of the European Personalised Medicine Association (EPEMED). Dr. Kroll received his doctorate in Physiological Chemistry from the University of Marburg.

Research Interest

 Business